A small-cap biopharmaceutical company focused on developing and commercializing therapeutics and diagnostic tests, primarily in endocrinology and oncology. Its key asset is macimorelin, an oral diagnostic for adult growth hormone deficiency, while the broader pipeline targets cancer and other specia...
1 member of Congress has disclosed 3 trades in Aeterna Zentaris Inc (AESX), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-01-04 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2018-01-03 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2018-01-02 | MICHAEL T. MCCAUL | buy | $1K – $15K |